BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Adipose tissue
,
Amniocentesis
,
Fenofibrate
,
rs2476601
,
BRCA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
DNA topoisomerase type I activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Spinal cord
Substantia nigra
Temporal lobe
Midbrain
Lymph nodes
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Tinea pedis
Vesicular stomatitis Indiana virus disease
Malaria
Listeriosis
Microcephalus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Poliovirus Vaccines
schizandrer A
Gene Products, gag
Geneticin
Tetanus Toxin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-365a-3p
HR
PPP2R2C
NDUFC2
COG7
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
Immunogenic activity of septic patients' plasma
Metastatic malignant melanoma tumor biopsies from a population-based cohort
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
L1000 CMAP Lung cancer NCI-H1299 cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for DNA topoisomerase type I activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubic…
Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide
Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibito…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ